In the latest trading session, Novo Nordisk (NVO) closed at $38.26, marking a +1.95% move from the previous day. This change outpaced the S&P 500's 0.22% loss on the day. Elsewhere, the Dow saw a downswing of 0.66%, while the tech-heavy Nasdaq depreciated by 0.22%. Heading into today, shares of the drugmaker had lost 16.9% over the past month, lagging the Medical sector's loss of 4.73% and the S&P 500's gain of 1.4%. Analysts and investors alike will be keeping a close eye on the performance of Novo Nordisk in its upcoming earnings disclosure. The company is expected to report EPS of $0.8, down 21.57% from the prior-year quarter. In the meantime, our current consensus estimate forecasts the revenue to be $11.41 billion, indicating a 2.
Mostramos publicamente o ponto principal. Crie uma conta gratuita para continuar lendo o artigo completo, salva-lo, comenta-lo e conecta-lo ao contexto de mercado e OSINT.